funny, I was just thinking: in the end, when all of the slides are side and done, what new data has reinforced the thesis that 2-73 works effectively? Hard data. Efficacy data. None. In fact, based on prior posts on this board, the contrary could be argued: 1) super-responders were mostly MCI, a notoriously difficult cohort to assess and diagnose when screening, 2) other studies have shown wild variation in MMSE scores over time, with scores either improving or stabilizing in up to 15-20% of the three years (this has been pointed out by a few posters ad nauseum), and 3) there is no placebo arm, which, I believe, if there was, it would steal thunder from the super-responder noise.
I know it's hard to believe, but I do hold a long position, but I am not as enthusiastic about the data in the presentation as many here.